FDA leverages private sector technology-based tools in its embrace of real world evidence

In this article for Forbes, John Osborn writes about the U.S. Food & Drug Administration accessing private sector technology-based tools as a means of incorporating real world data and evidence into its drug approval, label expansion, and regulatory oversight tasks.

Read More: FDA leverages private sector technology-based tools in its embrace of real world evidence


Download PDF Back To Listing
Loading data